Molecular diagnostic technologies for COVID-19: Limitations and challenges

Area of Science:

• Biomedical diagnostics
• Infectious disease detection
• Molecular biology

Background:

• The COVID-19 pandemic necessitates rapid and accurate diagnostic systems for SARS-CoV-2.
• Commercially available COVID-19 diagnostics exist but face limitations, including false positives/negatives.
• Early infection stages pose challenges for current diagnostic technologies.

Purpose of the Study:

• To review recent advancements in molecular COVID-19 diagnostics.
• To analyze the clinical performance data of these diagnostic tools.
• To identify limitations and future challenges in infectious disease diagnostics.

Main Methods:

• Literature survey of molecular diagnostic technologies for COVID-19.
• Performance-based analysis of commercial and pre-commercial diagnostics.
• Evaluation of diagnostic accuracy and limitations.

Main Results:

• Commercial molecular diagnostics for SARS-CoV-2 have varying performance metrics.
• Limitations in sensitivity and specificity were noted, particularly in early infection.
• Analysis highlights the need for improved diagnostic accuracy and speed.

Conclusions:

• Molecular diagnostics are vital for COVID-19 management.
• Current technologies require further development to overcome limitations.
• Future research should focus on timely, rapid, low-cost, and accurate diagnostics for emerging diseases.